Concerns & Risks -- 7.5/10

SPGI trades at ~22x NTM P/E (FY2026E), well below its 5-year average of ~28x and 10-year median of ~33x. The FCF yield of ~3.9% is above historical averages. This valuation compression reflects (1) FY2026 guidance slightly below consensus, (2) macro/tariff uncertainty weighing on capital markets sentiment, and (3) Mobility spin-off execution questions. For a business with oligopoly economics, 75%+ recurring revenue, and ~50% operating margins, this represents an attractive entry point with manageable risks. Five upside catalysts and six downside risks are assessed below. Weight: 15%

P/E (TTM)

~28x

Below 10-year median of ~33x

P/E (NTM, FY2026E)

~22x

vs 5-year avg ~28x | reasonable

FCF Yield

~3.9%

Above historical avg ~3.0%

Consensus PT

~$607

41% upside | 15 analysts cover

Valuation snapshot

Multiple	Current	5-Year Avg	Assessment
P/E (TTM)	~28x	~33x	Below historical average; 15% below 10-year median
P/E (NTM, FY2026E)	~22x	~28x	Reasonable for a high-quality compounder
FCF Yield	~3.9%	~3.0%	Above historical average; attractive

Key catalysts (bull case)

#	Catalyst	Timing	Impact
1	Mobility Spin-Off	Mid-2026 \| Investor Day May 12, 2026	HIGH
RemainCo will be a purer data/analytics/ratings business at ~50%+ margins. Spin unlocks value; Mobility Global Investor Day May 12, 2026 could re-rate both entities.
2	Private Credit & Alt Data Supercycle	Ongoing	HIGH
Private markets revenue growing 20%+. With Intelligence + Cambridge Mercer + iLevel creates an integrated private markets data platform in a multi-trillion-dollar asset class.
3	Rate Cuts / Issuance Recovery	2026 (macro dependent)	HIGH
If the Fed cuts rates in 2026, high-yield and bank loan issuance could inflect, driving Ratings upside. Near-term maturity walls 3-5% higher than a year ago.
4	AI Product Monetization	Ongoing (Kensho scaling)	EMERGING
Management deliberately not quantifying AI revenue contribution. Kensho-powered tools driving retention, new sales, and competitive wins across all divisions.
5	Buyback Acceleration	Q1 2026 (~$1B)	HIGH
$1B in Q1 2026 alone vs. $650M in Q1 2025. At current valuation, this is highly accretive to EPS. Management is effectively voting with their balance sheet.

Key risks (bear case)

#	Risk	Severity	Detail / Mitigant
1	Ratings Cyclicality	MEDIUM	A recession or sustained tariff escalation could suppress debt issuance. Q4 2025 saw investment-grade mix shift lowering effective monetization. Bank loan softness flagged by management. Mitigant: secular growth in global debt outstanding; 75%+ of total revenue is recurring.
2	MI Growth Deceleration	MEDIUM	Market Intelligence organic growth has been ~5-6%, slower than other segments. The market questions whether MI can sustain 7%+ growth. Mitigant: ACV accelerated to 6.5-7.0% in H2 2025; private markets revenue growing 21%.
3	Regulatory Risk	LOW-MEDIUM	Credit rating agencies face periodic regulatory scrutiny (EU, DOJ). Any structural reform to the issuer-pays model would be existential, though highly unlikely given entrenched regulatory framework.
4	Bloomberg/MSCI Competition	MEDIUM	Bloomberg Terminal remains the dominant platform in trading/sales. MSCI competes in ESG, index, and analytics. FactSet competes in buy-side data. Mitigant: SPGI moat is widening through data breadth and AI capabilities.
5	Spin-Off Execution Risk	MEDIUM	Mobility separation requires Form 10, tax opinion, and board approval. Any delay or adverse market conditions could push timing or create dissynergies. Mitigant: management describes stranded costs as "relatively immaterial."
6	Macro/Tariff Overhang	MEDIUM	Management explicitly lowered GDP assumptions and raised inflation expectations for 2025. Trade conflicts create near-term uncertainty for capital markets activity. Mitigant: 75%+ recurring revenue provides stability.

Assessment: catalysts outweigh risks

Verdict: The risk/reward is favorable. Five high-impact catalysts (Mobility spin-off, private markets supercycle, rate cut/issuance recovery, AI monetization, buyback acceleration) are set against six medium-severity risks -- none of which threaten the fundamental moat. Ratings cyclicality is real but mitigated by 75%+ recurring revenue and secular growth in global debt. MI growth deceleration is the most-watched risk but ACV acceleration in H2 2025 is encouraging. Regulatory risk to the issuer-pays model is low probability. The valuation at ~22x NTM P/E (vs. ~28x 5-year avg) prices in near-term headwinds while the upside catalysts are underappreciated by the market.

Score rationale

7.5/10. The score reflects a constructive risk/reward balance. The valuation discount is genuine -- ~22x NTM P/E vs. a 5-year average of ~28x, with FCF yield above historical averages at ~3.9%. Five material upside catalysts provide multiple paths to re-rating. The risk stack is moderate: Ratings cyclicality, MI growth, and spin-off execution are all real but none threaten the structural moat.

The score does not reach 8 or higher because: (a) Ratings cyclicality creates genuine downside risk in a recession scenario -- ~31% of revenue is tied to debt issuance volumes; (b) MI growth at 5-6% is below where bulls want it; (c) the Mobility spin-off adds execution complexity in 2026; and (d) macro/tariff uncertainty is a real near-term overhang on capital markets activity.

The score does not fall below 7.5 because: (a) the moat is among the widest in the coverage universe (triopoly in ratings, monopoly in indices); (b) 75%+ recurring revenue provides substantial downside protection; (c) management is responding with the right playbook (accelerated buybacks, no transformational M&A); and (d) 15 analysts cover SPGI with 33% Strong Buy and 67% Buy, 0% Hold/Sell, and a consensus price target of ~$607 implying 41% upside.

Data sourced from Daloopa, company filings, and earnings transcripts.